These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34666796)

  • 21. [Clinical characteristics of the Wilson disease carrier].
    Zhou XX; He RX; Pu XY; Li XH; Qin HL; Huang HW; Liang XL
    Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(11):806-811. PubMed ID: 30893721
    [No Abstract]   [Full Text] [Related]  

  • 22. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The diagnostic value and limits of diagnostic parameters for Wilson's disease].
    Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):881-885. PubMed ID: 29325287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures.
    Turner-Bowker DM; An Haack K; Krohe M; Yaworsky A; Vivas N; Kelly M; Chatterjee G; Chaston E; Mann E; Reaney M
    J Patient Rep Outcomes; 2020 Oct; 4(1):80. PubMed ID: 33000327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the Patient Perception of Statin Experience: A Qualitative Study.
    Vrablik M; Catapano AL; Wiklund O; Qian Y; Rane P; Grove A; Martin ML
    Adv Ther; 2019 Oct; 36(10):2723-2743. PubMed ID: 31482507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.
    Flythe JE; Karlsson N; Sundgren A; Cordero P; Grandinetti A; Cremisi H; Rydén A
    BMC Nephrol; 2021 Jun; 22(1):233. PubMed ID: 34162354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of clinical and biochemical spectrum of Wilson disease patients.
    Mansoor S; Naveed AK; Majeed A
    Indian J Pathol Microbiol; 2012; 55(3):365-9. PubMed ID: 23032833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting activities of daily living among patients with Wilson disease.
    Amemiya A; Asakura K; Nishiwaki Y; Shimizu N
    J Inherit Metab Dis; 2023 Jul; 46(4):735-743. PubMed ID: 37204330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a disease conceptual model of patient experience with metastatic colorectal cancer: identification of the most salient symptoms and impacts.
    Guillemin I; Darpelly M; Wong B; Ingelgård A; Griebsch I
    J Cancer Surviv; 2024 Jun; 18(3):761-771. PubMed ID: 36515691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient and caregiver perspectives on burden of disease manifestations in late-onset Tay-Sachs and Sandhoff diseases.
    Lyn N; Pulikottil-Jacob R; Rochmann C; Krupnick R; Gwaltney C; Stephens N; Kissell J; Cox GF; Fischer T; Hamed A
    Orphanet J Rare Dis; 2020 Apr; 15(1):92. PubMed ID: 32295606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Unusual history of Wilson disease: a case report and review of the literature].
    Nehaj F; Kubašková M; Mokáň M; Sokol J; Nosáľ V; Zeleňák K; Mokáň M
    Vnitr Lek; 2018; 63(12):980-986. PubMed ID: 29334749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilson disease.
    Guindi M
    Semin Diagn Pathol; 2019 Nov; 36(6):415-422. PubMed ID: 31421978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive profile in Wilson's disease: a case series of 31 patients.
    Wenisch E; De Tassigny A; Trocello JM; Beretti J; Girardot-Tinant N; Woimant F
    Rev Neurol (Paris); 2013 Dec; 169(12):944-9. PubMed ID: 24120329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric and behavioral abnormalities in Wilson's disease.
    Akil M; Brewer GJ
    Adv Neurol; 1995; 65():171-8. PubMed ID: 7872138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the Patient Experience in NUT Carcinoma: Qualitative Interviews with Patients and Caregivers to Develop a Conceptual Framework.
    Pompilus F; Ciesluk A; Marquis P; Griebsch I; Voorhaar M
    Oncol Ther; 2021 Dec; 9(2):591-605. PubMed ID: 34357582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson's Disease: A Qualitative Study.
    Staunton H; Kelly K; Newton L; Leddin M; Rodriguez-Esteban R; Chaudhuri KR; Weintraub D; Postuma RB; Martinez-Martin P
    J Parkinsons Dis; 2022; 12(1):137-151. PubMed ID: 34657850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social and demographic characteristics of a Polish cohort with Wilson disease and the impact of treatment persistence.
    Maselbas W; Litwin T; Czlonkowska A
    Orphanet J Rare Dis; 2019 Jul; 14(1):167. PubMed ID: 31277686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving Assessment of Adherence Behaviors and Drivers: Targeted Literature Review and Concept Elicitation Interviews in Multiple Countries and Disease Populations.
    Bentley S; Exall E; Morgan L; Roche N; Khunti K; Rossom R; Piercy J; Arbuckle R; Higgins VS
    Patient Prefer Adherence; 2024; 18():1231-1242. PubMed ID: 38911591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin a nephropathy as the first clinical presentation of Wilson disease: a case report and literature review.
    Zhang YZ; Jian G; He P; Yu R; Tian M; Wu Y; Zhang BR
    BMC Gastroenterol; 2021 Oct; 21(1):384. PubMed ID: 34666712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological features and outcomes of Wilson's disease: a single-center experience.
    Samanci B; Sahin E; Bilgic B; Tufekcioglu Z; Gurvit H; Emre M; Demir K; Hanagasi HA
    Neurol Sci; 2021 Sep; 42(9):3829-3834. PubMed ID: 33474589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.